Objectives The study determined the prevalence of hospitalisation due to congestive heart failure (CHF) among adult patients aged 19 years and above in the Philippines and its 17 regions in 2014. It also determined the demographic profile of these patients, aetiology and type of CHF, comorbidities, duration of hospitalisation and the overall in-hospital mortality rate.
Methods Data collection was done using the hospitalisation claims database of the Philippine Health Insurance Corporation (PhilHealth). All patient claims for CHF, that is, patients who were admitted from 1 January to 31 December 2014, were included. Descriptive statistics were utilised to obtain the results.
Results The prevalence rate was 1.6% or 1648 cases of CHF for every 100 000 patient claims for medical conditions in 2014. The mean age was 52.6±15.1 years. There was no sex predilection. Only 22.67% of the hospitalisation claims for CHF listed possible specific aetiologies, the most common of which was hypertensive heart disease (86.7%). There were more cases of systolic compared to diastolic heart failure. The mean length of hospital stay was 5.9 days (+8.2) days (median 4 days), with an overall in-hospital mortality rate of 8.2%.
Conclusions There were 16 cases of heart failure for every 1000 Filipino patients admitted due to a medical condition in 2014. Hypertension was possibly the most common aetiologic factor. Compared to western and Asia-Pacific countries, the local mortality rate was relatively higher.
- HEART FAILURE
Statistics from Altmetric.com
Contributors All authors have contributed to the protocol development. BATM and AB-DS polished the protocol, monitored the collection of data, prepared the draft of the paper and did revisions before submission to Heart Asia. VLM cleaned and analysed the data, as well as contributing to the writing/revision of the drafts. FEP reviewed the draft of the paper before submission for possible publication and gave important input. NSP, RBN, LAS and RN also contributed to the data collection. BAT-M is the guarantor. All authors have given approval to this version for publication.
Funding Funding was through a research grant to De La Salle Health Sciences Institute, Dasmarinas, Cavite by Novartis Healthcare Philippines, Inc. The sponsor did not interfere in the any part of the development of the paper.
Competing interests None declared.
Ethics approval Institutional Ethics Committee, De La Salle Health Sciences Institute.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.